MEPs amend two elements of pharma package

摘要

Members of the European Parliament's Committee on the Environment and Public Health (ENVI) approved by a large majority, on 27 April, amendments to two elements of the pharmaceuticals package: prevention of the introduction of counterfeit medicines in the legal supply chain and update of pharmaco-vigilance rules. The plenary will vote in June or July.